You could be reading the full-text of this article now if you...

If you have access to this article through your institution,
you can view this article in

Intrathecal Vincristine: 3 Fatal Cases and a Review of the Literature

Hennipman, Bernadette MBBS*; de Vries, Esther MD, PhD; Bökkerink, Jos P. M. MD, PhD‡ §; Ball, Lynn M. MD, FRCP, FRCPath, FRCPCH; Veerman, Anjo J. P. MD, PhD* §

Journal of Pediatric Hematology/Oncology:
doi: 10.1097/MPH.0b013e3181b83fba
Original Articles
Abstract

We report 3 cases of accidental intrathecal vincristine administration. All 3 patients died between 8 and 18 days after the incident because of decerebration. In the literature, we found 41 cases of accidental intrathecal injection of vincristine. These reports represent only a fraction of the existing problem. New in our report is the fact that the first 2 cases were attributed to viral infection, only after the detection of high levels of vincristine in the cerebrospinal fluid was the real cause of death ascertained. The third case occurred during the implementation of rules by the Dutch Childhood Oncology Group on how to handle intrathecal triple therapy; and despite sequential safety measures, the accident still occurred. In the Netherlands no more accidents of this nature have occurred in children after the introduction of a quadruple syringe system 8 years ago. In our opinion the best fail-safe solution would be the development of a unique connection that is incompatible with a standard Luer syringe.

Author Information

*Department of Paediatric Oncology/Haematology, Vrije Universiteit Medical Centre, Amsterdam

Department of Paediatrics, Jeroen Bosch Hospital, ‘s Hertogenbosch

Department of Paediatric Haematology and Oncology, University Medical Hospital St Radboud, Nimegen

§Dutch Childhood Oncology Group (DCOG) the Hague

Department of Paediatric Haematology and Oncology, Leiden University Medical Centre, Leiden, The Netherlands

Reprints: Anjo J. P. Veerman, MD, PhD, Department of Paediatric Haematology and Oncology, Vrije Universiteit University Medical Centre, Postbus 7057, 1007 MB Amsterdam, The Netherlands (e-mail: ajp.veerman@vumc.nl).

Received for publication September 10, 2008

accepted July 18, 2009

© 2009 Lippincott Williams & Wilkins, Inc.